Samuel C. Blackman, HEAD OF R&D at Day One Biopharmaceuticals, Inc. (DAWN), sold 30,000 shares at $14.22 ($427K) on 2024-09-10, disclosed to the SEC on 2024-09-12.
Scheduled sale ($427k) by HEAD OF R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DAWN | SELL | 2024-11-12 | $751K | — | Filing → |
| DAWN | SELL | 2024-11-08 | $361K | — | Filing → |
| DAWN | SELL | 2024-11-04 | $8K | — | Filing → |